Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye conditionCNBC • 07/04/24
Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To BlindnessInvestors Business Daily • 07/03/24
Surprise! Novo Nordisk's Wegovy Just Achieved Another Milestone. Here's What You Need to Know.The Motley Fool • 06/30/24
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment lossGlobeNewsWire • 06/26/24
Wegovy Approved In China—But Novo Nordisk Promises Existing Patients Priority Amid ShortagesForbes • 06/25/24